| |||
| Combination of | |||
|---|---|---|---|
| Clindamycin | Antibiotic | ||
| Benzoyl peroxide | Antiseptic | ||
| Clinical data | |||
| Trade names | Benzaclin, others | ||
| AHFS/Drugs.com | Multum Consumer Information | ||
| MedlinePlus | a603021 | ||
| License data | |||
| Pregnancy category |
| ||
| Routes of administration | Topical | ||
| ATC code | |||
| Legal status | |||
| Legal status | |||
| Identifiers | |||
| CAS Number | |||
| PubChem CID | |||
| KEGG | |||
  (what is this?) (verify) | |||
Clindamycin/benzoyl peroxide, sold under the brand name Benzaclin among others, is a topical gel used for the treatment of acne.[7] It is a fixed-dose combination of clindamycin, as the phosphate, an antibiotic; and benzoyl peroxide, an antiseptic.[7]
Common side effects include peeling, itching, and dryness of the skin where the gel was applied.[7]
Clindamycin/benzoyl peroxide was approved for medical use in the United States in December 2000.[12][13][14] It is available as a generic medication.[15]
- ^ "Prescribing medicines in pregnancy database". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 8 July 2024.
- ^ http://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=406130&agid=%28PrintDetailsPublic%29&actionid=1 [bare URL]
- ^ "TGA eBS - Product and Consumer Medicine Information Licence".
- ^ "Novadac once daily gel (Nova Pharmaceuticals Australasia Pty Ltd)". Therapeutic Goods Administration (TGA). 1 July 2024. Retrieved 8 July 2024.
- ^ "Duac Once Daily 10 mg/g + 30 mg/g Gel - Summary of Product Characteristics (SmPC)". (emc). 30 April 2021. Archived from the original on 4 February 2022. Retrieved 26 August 2022.
- ^ "Clindamycin + Benzoyl Peroxide 10mg/g + 50mg/g Gel - Summary of Product Characteristics (SmPC)". (emc). 14 June 2021. Archived from the original on 22 September 2021. Retrieved 26 August 2022.
- ^ a b c d "Benzaclin- clindamycin phosphate and benzoyl peroxide gel". DailyMed. 16 February 2017. Archived from the original on 19 January 2022. Retrieved 26 August 2022.
- ^ "Acanya- clindamycin phosphate and benzoyl peroxide gel". DailyMed. 30 September 2020. Archived from the original on 24 March 2021. Retrieved 26 August 2022.
- ^ "Onexton- clindamycin phosphate and benzoyl peroxide gel". DailyMed. 6 April 2020. Archived from the original on 26 August 2022. Retrieved 26 August 2022.
- ^ "Duac (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/5%for topical use Initial U.S. Approval: 2000". DailyMed. 15 April 2015. Archived from the original on 26 August 2022. Retrieved 26 August 2022.
- ^ "Regulatory Update -- Stiefel, a GSK company announces a new, alternate, fixed-dose combination of Duac (clindamycin 1% and benzoyl peroxide 3%) gains positive recommendation for approval in Europe" (Press release). GlaxoSmithKline. 4 March 2013. Archived from the original on 4 December 2020. Retrieved 26 August 2022 – via PR Newswire.
- ^ "Drug Approval Package: Benzaclin (Clindamycin 1% and Benzoyl Peroxide 5%) NDA #50-756". U.S. Food and Drug Administration (FDA). 24 December 1999. Archived from the original on 2 April 2021. Retrieved 26 August 2022.
- ^ "Drug Approval Package: Duac (clindamycin, benzyoyl) NDA #050741". U.S. Food and Drug Administration (FDA). 27 April 2003. Archived from the original on 11 April 2021. Retrieved 26 August 2022.
- ^ "Drug Approval Package: Acanya (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) Gel NDA #050819". U.S. Food and Drug Administration (FDA). 29 October 2009. Archived from the original on 14 May 2021. Retrieved 26 August 2022.
- ^ "Perrigo Receives FDA Approval and Commences Launch of Clindamycin Phosphate and Benzoyl Peroxide 1.2% / 5% Gel" (Press release). Perrigo Company. 27 June 2012. Archived from the original on 26 August 2022. Retrieved 26 August 2022 – via PR Newswire.